Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze DRUG.CX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate DRUG.CX investment potential.

What is DRUG.CX stock price today?

Get real-time DRUG.CX stock price, historical data, and price charts on Financhill. Track DRUG.CX performance with our advanced analysis tools.

Is DRUG.CX a good investment?

Evaluate DRUG.CX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy DRUG.CX stock?

To buy DRUG.CX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of DRUG.CX?

View detailed market capitalization data and company valuation metrics for DRUG.CX on our comprehensive analysis page.

What is the P/E ratio of DRUG.CX?

Use our fundamental analysis tools to view DRUG.CX P/E ratio and compare valuation metrics with industry peers.

What are DRUG.CX earnings?

View DRUG.CX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Bright Minds Biosciences, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

DRUG.CX
Bright Minds Biosciences, Inc.

Last Price:

$118.29

Seasonality Move:

-25.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Bright Minds Biosciences, Inc. Stock Forecast

Over the next 52 weeks, Bright Minds Biosciences, Inc. has on average historically risen by 779.7% based on the past 4 years of stock performance.
Bright Minds Biosciences, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Bright Minds Biosciences, Inc. Stock Undervalued?

The current Bright Minds Biosciences, Inc. [DRUG.CX] share price is $114.23. The Score for DRUG.CX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
DRUG.CX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Bright Minds Biosciences, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Bright Minds Biosciences, Inc. has on average historically risen by 779.7% based on the past 4 years of stock performance.

Bright Minds Biosciences, Inc. Stock Rating

Buy

Bright Minds Biosciences, Inc. (DRUG.CX) is a Buy

Is Bright Minds Biosciences, Inc. overpriced?

Bright Minds Biosciences, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Bright Minds Biosciences, Inc. Stock Price History

Is DRUG.CX stock going to rise?

The current trend is moderately bullish and DRUG.CX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

CNSX

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

brightmindsbio.com

52-Week Data

52-Week High:

131.88

52-Week Low:

33.01

Prediction Charts

Market Cap:

809.7M

Price in USD:

114.23

Volume:

6.1K

Beta:

-2.06

Technical Analysis

SMA50:

92.95

SMA100:

78.12

SMA200:

60.31

52-Wk Change:

109.44%

Stock Predictions

Is Bright Minds Biosciences, Inc. stock public?

Yes, Bright Minds Biosciences, Inc. is a publicly traded company.
What is the Bright Minds Biosciences, Inc. stock quote today?

The Bright Minds Biosciences, Inc. stock price is 114.23 USD today.
How to buy Bright Minds Biosciences, Inc. stock online?

You can buy Bright Minds Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-3	103.64	101.45	103.64	101.45
Dec-4	100.14	100.00	102.37	100.00
Dec-5	102.02	106.49	106.49	101.71
Dec-8	110.40	114.34	119.00	110.40
Dec-9	112.68	108.26	112.68	108.26
Dec-10	110.39	117.45	117.61	110.39
Dec-11	116.95	122.72	122.80	116.95
Dec-12	113.11	115.88	116.82	113.10
Dec-15	119.01	118.34	119.01	117.96
Dec-16	124.91	131.88	131.88	121.86
Dec-17	122.20	122.40	122.40	116.72
Dec-18	114.12	110.03	115.25	108.34
Dec-19	111.99	116.00	118.20	111.99
Dec-22	116.00	114.23	116.00	112.44

Bright Minds Biosciences, Inc. Earnings

Bright Minds Biosciences, Inc. Earnings Report: Per Share Bright Minds Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Bright Minds Biosciences, Inc. Forecast Revenue Growth

Bright Minds Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Bright Minds Biosciences, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.20 per share, and a decrease next year of $4.60 per share.

* Bright Minds Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.